Magnetic Headset Therapy Improved Long COVID Cognition
A clinical trial found that noninvasive magnetic fields helped adults recover memory and processing speed.
Updated on Sept. 30, 2026 in Alzheimer’s

Live Poll
Would you trust a home-based experimental medical device to treat your chronic health symptoms?
A randomized, triple-blind study has shown that a magnetic headset improved cognitive function and well-being in adults suffering from long COVID. Participants using the device for four weeks demonstrated gains in working memory, processing speed, and verbal learning.
Why it matters
Researchers are exploring whether biophysical neuromodulation can address post-viral neurological symptoms that affect millions of people. This trial suggests that noninvasive magnetic therapy could serve as a viable intervention for long-term cognitive impairment.
The study utilized a 15-minute Microtesla Magnetic Therapy session twice weekly, with participants exceeding an 80% protocol completion threshold. No significant device-related adverse events were reported during the trial.
The players
Mount Sinai
This is a prominent academic medical center and research institution based in New York that leads diverse clinical trials.
The details
Participants self-administered the nonthermal radio-frequency headset at home while under remote monitoring by researchers at Mount Sinai. The study randomized participants 2:1 between active treatment and a sham device to measure improvements in neurological health.
Timeline
September 22, 2026: The study was published in the journal Brain Communications.
Week 4: The treatment intervention concluded for all participants.
Week 8: Researchers conducted follow-up assessments to verify sustained cognitive gains.
The Big Picture
This study contributes to the clinical investigation of biophysical neuromodulation, a field currently seeking non-pharmaceutical approaches to neurological damage. It establishes a potential pathway for treating post-viral syndromes using low-amplitude magnetic fields.
For those managing long COVID, this study indicates that noninvasive, home-based neuro-therapy may eventually provide a way to address cognitive fog without the side effects of traditional medications. However, patients should wait for further research to determine if this therapy will become a standard clinical option.
The takeaway
This study highlights the potential for noninvasive medical devices to treat complex neurological conditions from the comfort of home. Future clinical applications depend on researchers successfully verifying these results in larger, multicenter cohorts.
Further reading
Learn more about the latest research and interventions in Alzheimer’s.
Live Poll
Would you trust a home-based experimental medical device to treat your chronic health symptoms?







